Cite
MLA Citation
A Martin et al.. “P250 Informing the pathway of COPD treatment (the IMPACT study): single inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with COPD – cost-effectiveness in the UK.” Thorax, vol. 73, n.d., p. A237. http://access.bl.uk/ark:/81055/vdc_100144711605.0x000033